1. Home > Latest Topics >

Question 3: Changing guideline recommendations

20 June, 2018

Question 3
Would you agree that the changing recommendations in guidelines in various countries reflect the increasing recognition of the importance of fluoroquinolones in treating LRTIs?


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Fluoroquinolones for intra-abdominal infection
29 October, 2022
What is good clinical research?
03 October, 2022
Levofloxacin in the Treatment of Hospital-Acquired Pneumonia: Insights into Antibiotic Resistance and Tolerance
18 October, 2023
Lower Respiratory Tract Infection (Pneumonia) – Chapter 4
18 July, 2023
Lower Respiratory Tract Infections: AECOPD, Aspiration, and Pneumonia in the COVID-19 Era (Chapter 1)
24 November, 2022